ARCHIVES

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Court Filing By Fisher; Board, Attacks Interim NSABP Leadership

August 12, 1994

ORI Misconduct Findings Announced In Two Cases

July 12, 1996

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

June 15, 1984

New Mexico, Missouri, Columbia Next for Review As comprehensive Centers; UCLA Decision In October

September 17, 1976

ASH Highlights: Improved Treatments For NHL, Poor Prognostic Factors For B-Cell In Children

January 30, 2004

ACS To Implement Cancer Response Systems Nationwide

August 2, 1985